BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37096066)

  • 1. Sema4D silencing increases the sensitivity of nivolumab to B16-F10 resistant melanoma via inhibiting the PI3K/AKT signaling pathway.
    Zhang Z; Zhang D; Wang F; Liu J; Sun Y; Anuchapreeda S; Tima S; Xiao Z; Duangmano S
    PeerJ; 2023; 11():e15172. PubMed ID: 37096066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sema4D/Plexin-B1 promotes the progression of osteosarcoma cells by activating Pyk2-PI3K-AKT pathway.
    Li C; Wan L; Wang P; Guan X; Li C; Wang X
    J Musculoskelet Neuronal Interact; 2021 Dec; 21(4):577-583. PubMed ID: 34854398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plexin-B1 and semaphorin 4D cooperate to promote cutaneous squamous cell carcinoma cell proliferation, migration and invasion.
    Cao J; Zhang C; Chen T; Tian R; Sun S; Yu X; Xiao C; Wang G; Liu Y; Fu M; Li W
    J Dermatol Sci; 2015 Aug; 79(2):127-36. PubMed ID: 26051877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semaphorin 4D is a potential biomarker in pediatric leukemia and promotes leukemogenesis by activating PI3K/AKT and ERK signaling pathways.
    Jiang H; Tang J; Qiu L; Zhang Z; Shi S; Xue L; Kui L; Huang T; Nan W; Zhou B; Zhao C; Yu M; Sun Q
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SEMA4D/PlexinB1 promotes AML progression via activation of PI3K/Akt signaling.
    Liu L; Yang L; Liu X; Liu M; Liu J; Feng X; Nie Z; Luo J
    J Transl Med; 2022 Jul; 20(1):304. PubMed ID: 35794581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semaphorin 4D promotes the proliferation and metastasis of bladder cancer by activating the PI3K/AKT pathway.
    Lu JJ; Su YW; Wang CJ; Li DF; Zhou L
    Tumori; 2019 Jun; 105(3):231-242. PubMed ID: 30674231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plexin-B1 activates NF-κB and IL-8 to promote a pro-angiogenic response in endothelial cells.
    Yang YH; Zhou H; Binmadi NO; Proia P; Basile JR
    PLoS One; 2011; 6(10):e25826. PubMed ID: 22028792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of SEMA4D in recurrent implantation failure induces reduction of trophoblast invasion and migration via the Met/PI3K/Akt pathway.
    Chen X; Qi L; Zhao C; Xue J; Chen M; Diao L; He W; Lv B; Zeng Y; Xue Z
    J Reprod Immunol; 2022 Sep; 153():103657. PubMed ID: 35816784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo anti-malignant melanoma activity of Alocasia cucullata via modulation of the phosphatase and tensin homolog/phosphoinositide 3-kinase/AKT pathway.
    Fang M; Zhu D; Luo C; Li C; Zhu C; Ou J; Li H; Zhou Y; Huo C; Liu W; Peng J; Peng Q; Mo Z
    J Ethnopharmacol; 2018 Mar; 213():359-365. PubMed ID: 29180042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sema4D, the ligand for Plexin B1, suppresses c-Met activation and migration and promotes melanocyte survival and growth.
    Soong J; Chen Y; Shustef EM; Scott GA
    J Invest Dermatol; 2012 Apr; 132(4):1230-8. PubMed ID: 22189792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Berberine suppressed epithelial mesenchymal transition through cross-talk regulation of PI3K/AKT and RARα/RARβ in melanoma cells.
    Kou Y; Li L; Li H; Tan Y; Li B; Wang K; Du B
    Biochem Biophys Res Commun; 2016 Oct; 479(2):290-296. PubMed ID: 27639645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plexin B1 inhibits MET through direct association and regulates Shp2 expression in melanocytes.
    Soong J; Scott G
    J Cell Sci; 2013 Jan; 126(Pt 2):688-95. PubMed ID: 23203808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sinomenine inhibits the growth of melanoma by enhancement of autophagy via PI3K/AKT/mTOR inhibition.
    Sun Z; Zheng L; Liu X; Xing W; Liu X
    Drug Des Devel Ther; 2018; 12():2413-2421. PubMed ID: 30122899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gambogic acid exhibits anti-metastatic activity on malignant melanoma mainly through inhibition of PI3K/Akt and ERK signaling pathways.
    Li CY; Wang Q; Wang XM; Li GX; Shen S; Wei XL
    Eur J Pharmacol; 2019 Dec; 864():172719. PubMed ID: 31586634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of lncRNA H19 inhibits the migration and invasion of melanoma cells by inactivating the NF‑κB and PI3K/Akt signaling pathways.
    Liao Z; Zhao J; Yang Y
    Mol Med Rep; 2018 May; 17(5):7313-7318. PubMed ID: 29568965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. circ_NRIP1 is oncogenic in malignant development of esophageal squamous cell carcinoma (ESCC) via miR-595/SEMA4D axis and PI3K/AKT pathway.
    Zhou S; Guo Z; Zhou C; Zhang Y; Wang S
    Cancer Cell Int; 2021 May; 21(1):250. PubMed ID: 33957921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of capsaicin on B16-F10 melanoma cell migration via the phosphatidylinositol 3-kinase/Akt/Rac1 signal pathway.
    Shin DH; Kim OH; Jun HS; Kang MK
    Exp Mol Med; 2008 Oct; 40(5):486-94. PubMed ID: 18985006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAT3-induced upregulation of lncRNA SNHG17 predicts a poor prognosis of melanoma and promotes cell proliferation and metastasis through regulating PI3K-AKT pathway.
    Gao H; Liu R; Sun X
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):8000-8010. PubMed ID: 31599425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scutellarin inhibits the invasive potential of malignant melanoma cells through the suppression epithelial-mesenchymal transition and angiogenesis via the PI3K/Akt/mTOR signaling pathway.
    Li CY; Wang Q; Wang X; Li G; Shen S; Wei X
    Eur J Pharmacol; 2019 Sep; 858():172463. PubMed ID: 31211986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRAFV600E cooperates with PI3K signaling, independent of AKT, to regulate melanoma cell proliferation.
    Silva JM; Bulman C; McMahon M
    Mol Cancer Res; 2014 Mar; 12(3):447-63. PubMed ID: 24425783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.